Bio-Dot Scientific Equipments Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 21 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth %
- Profit Growth 60.58%
- Ebitda 66.35%
- Net Worth -20.60%
- Total Assets 5.92%
About Bio-Dot Scientific Equipments
Bio-Dot Scientific Equipments Private Limited. (BSEPL) is a Private Limited Indian Non-Government Company incorporated in India on 16 April 2003 and has a history of 21 years and ten months. Its registered office is in Delhi, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Upkar Pachori and Nirmal Pachori serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U51397DL2003PTC119900
- Company No.
119900
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Apr 2003
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
What products or services does Bio-Dot Scientific Equipments Private Limited. offer?
Bio-Dot Scientific Equipments Private Limited. offers a wide range of products and services, including Laboratory & Lab Equipment, Laboratory Bath.
Who are the key members and board of directors at Bio-Dot Scientific Equipments?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Upkar Pachori  | Director | 16-Apr-2003 | Current |
| Nirmal Pachori | Director | 01-Dec-2008 | Current |
Financial Performance of Bio-Dot Scientific Equipments.
Bio-Dot Scientific Equipments Private Limited., for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 60.58% increase in profit. The company's net worth observed a substantial decline by a decrease of 20.6%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bio-Dot Scientific Equipments?
In 2020, Bio-Dot Scientific Equipments had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Bio-Dot Scientific Equipments?
Unlock and access historical data on people associated with Bio-Dot Scientific Equipments, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bio-Dot Scientific Equipments, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bio-Dot Scientific Equipments's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.